Ewing Sarcoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Children with Ewing sarcoma should have their treatment planned by a team of health care providers who are experts in treating cancer in children.
The PDQ® cancer information summary provides current information about the treatment of childhood Ewing sarcoma, including clinical management, clinical trials, clinical assessment, follow‑up, psychosocial and survivorship issues for patients, families, and caregivers.
Ewing sarcoma is a rare but aggressive bone and soft‑tissue tumor that primarily affects adolescents and young adults. Early, multidisciplinary management with systemic and local therapies is critical to cure and preserve function.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- Revisiting CDKN2A dysregulation in Ewing sarcoma
- Emerging therapies in Ewing sarcoma
- Genome‑wide association study meta‑analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk
- Biochemists discover new strategy to combat pediatric bone cancer
- Integrated Immunotherapy Target Atlas for Ewing Sarcoma